A detailed history of Northwestern Mutual Wealth Management CO transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 11,263 shares of IONS stock, worth $411,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,263
Previous 11,213 0.45%
Holding current value
$411,437
Previous $534,000 15.54%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.06 - $51.86 $2,003 - $2,593
50 Added 0.45%
11,263 $451,000
Q2 2024

Aug 15, 2024

BUY
$36.45 - $47.7 $2,442 - $3,195
67 Added 0.6%
11,213 $534,000
Q4 2023

Feb 13, 2024

SELL
$43.39 - $51.63 $911 - $1,084
-21 Reduced 0.19%
11,146 $563,000
Q3 2023

Nov 14, 2023

BUY
$38.5 - $47.13 $174,097 - $213,121
4,522 Added 68.05%
11,167 $506,000
Q2 2023

Aug 14, 2023

SELL
$34.73 - $43.33 $8,925 - $11,135
-257 Reduced 3.72%
6,645 $272,000
Q1 2023

May 15, 2023

SELL
$33.58 - $41.2 $503 - $618
-15 Reduced 0.22%
6,902 $246,000
Q4 2022

Feb 21, 2023

SELL
$37.12 - $46.52 $12,249 - $15,351
-330 Reduced 4.55%
6,917 $261,000
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $9,792 - $13,040
268 Added 3.84%
7,247 $320,000
Q2 2022

Aug 04, 2022

BUY
$31.71 - $43.0 $149,544 - $202,788
4,716 Added 208.4%
6,979 $258,000
Q1 2022

May 09, 2022

BUY
$29.88 - $37.04 $9,173 - $11,371
307 Added 15.7%
2,263 $83,000
Q4 2021

Feb 03, 2022

SELL
$25.61 - $35.1 $1,434 - $1,965
-56 Reduced 2.78%
1,956 $60,000
Q3 2021

Nov 15, 2021

BUY
$33.54 - $40.55 $16,233 - $19,626
484 Added 31.68%
2,012 $68,000
Q2 2021

Aug 13, 2021

SELL
$34.54 - $47.25 $14,195 - $19,419
-411 Reduced 21.2%
1,528 $61,000
Q1 2021

May 14, 2021

BUY
$42.51 - $63.78 $29,501 - $44,263
694 Added 55.74%
1,939 $86,000
Q4 2020

Feb 12, 2021

BUY
$45.3 - $60.27 $634 - $843
14 Added 1.14%
1,245 $70,000
Q3 2020

Nov 13, 2020

BUY
$47.45 - $62.95 $10,676 - $14,163
225 Added 22.37%
1,231 $59,000
Q2 2020

Aug 14, 2020

SELL
$46.85 - $61.05 $23,987 - $31,257
-512 Reduced 33.73%
1,006 $59,000
Q1 2020

May 08, 2020

BUY
$41.6 - $63.4 $25,916 - $39,498
623 Added 69.61%
1,518 $71,000
Q4 2019

Feb 13, 2020

SELL
$53.85 - $65.27 $36,025 - $43,665
-669 Reduced 42.77%
895 $55,000
Q3 2019

Nov 12, 2019

BUY
$59.06 - $72.15 $354 - $432
6 Added 0.39%
1,564 $93,000
Q2 2019

Aug 12, 2019

BUY
$62.09 - $86.14 $4,532 - $6,288
73 Added 4.92%
1,558 $100,000
Q1 2019

May 10, 2019

BUY
$52.92 - $81.17 $8,467 - $12,987
160 Added 12.08%
1,485 $121,000
Q4 2018

Feb 12, 2019

SELL
$43.37 - $59.54 $173 - $238
-4 Reduced 0.3%
1,325 $72,000
Q3 2018

Nov 01, 2018

SELL
$42.88 - $53.7 $5,703 - $7,142
-133 Reduced 9.1%
1,329 $69,000
Q1 2018

May 14, 2018

BUY
$44.08 - $55.05 $29,092 - $36,333
660 Added 82.29%
1,462 $64,000
Q4 2017

Jan 31, 2018

SELL
$50.3 - $64.39 $301 - $386
-6 Reduced 0.74%
802 $40,000
Q3 2017

Nov 07, 2017

BUY
$45.56 - $59.57 $15,900 - $20,789
349 Added 76.03%
808 $41,000
Q2 2017

Aug 10, 2017

BUY
N/A
459
459 $23,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.